Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

In Kyung Sung

Showing results (161-170 of 166) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 166 results.
Journal of Gastroenterology and Hepatology|February 8, 2026
Second Asian Consensus Report on Functional Dyspepsia (2025): Updated RecommendationsSanjiv Mahadeva, Kewin Tien Ho Siah, Uday C Ghoshal, et al.
World Journal of Gastroenterology|December 12, 2022
Randomized controlled trial to evaluate the efficacy and safety of fexuprazan compared with esomeprazole in erosive esophagitisKang Nyeong Lee, Oh Young Lee, Hoon Jai Chun, et al.
Gut and Liver|April 8, 2021
Efficacy and Safety of Rebamipide versus Its New Formulation, AD-203, in Patients with Erosive Gastritis: A Randomized, Double-Blind, Active Control, Noninferiority, Multicenter, Phase 3 StudyGwang Ha Kim, Hang Lak Lee, Moon Kyung Joo, et al.
Alimentary Pharmacology & Therapeutics|October 31, 2022
Randomised clinical trial: comparison of tegoprazan and lansoprazole as maintenance therapy for healed mild erosive oesophagitisYu Kyung Cho, Jae Hak Kim, Hyun-Soo Kim, et al.
Alimentary Pharmacology & Therapeutics|March 8, 2019
Randomised phase 3 trial: tegoprazan, a novel potassium-competitive acid blocker, vs. esomeprazole in patients with erosive oesophagitisKwang Jae Lee, Byoung Kwan Son, Gwang Ha Kim, et al.
Gut and Liver|June 22, 2026
A Phase III, Randomized, Double-Blind, Active-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Tegoprazan for the Prevention of Peptic Ulcer in Patients on Continuous Long-Term Treatment with Nonsteroidal Anti-Inflammatory DrugsSang Gyun Kim, Tae-Oh Kim, Sung Woo Jung, et al.
Pageof 17

Showing results (161-170 of 166) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 166 results.
Journal of Gastroenterology and Hepatology|February 8, 2026
Second Asian Consensus Report on Functional Dyspepsia (2025): Updated RecommendationsSanjiv Mahadeva, Kewin Tien Ho Siah, Uday C Ghoshal, et al.
World Journal of Gastroenterology|December 12, 2022
Randomized controlled trial to evaluate the efficacy and safety of fexuprazan compared with esomeprazole in erosive esophagitisKang Nyeong Lee, Oh Young Lee, Hoon Jai Chun, et al.
Gut and Liver|April 8, 2021
Efficacy and Safety of Rebamipide versus Its New Formulation, AD-203, in Patients with Erosive Gastritis: A Randomized, Double-Blind, Active Control, Noninferiority, Multicenter, Phase 3 StudyGwang Ha Kim, Hang Lak Lee, Moon Kyung Joo, et al.
Alimentary Pharmacology & Therapeutics|October 31, 2022
Randomised clinical trial: comparison of tegoprazan and lansoprazole as maintenance therapy for healed mild erosive oesophagitisYu Kyung Cho, Jae Hak Kim, Hyun-Soo Kim, et al.
Alimentary Pharmacology & Therapeutics|March 8, 2019
Randomised phase 3 trial: tegoprazan, a novel potassium-competitive acid blocker, vs. esomeprazole in patients with erosive oesophagitisKwang Jae Lee, Byoung Kwan Son, Gwang Ha Kim, et al.
Gut and Liver|June 22, 2026
A Phase III, Randomized, Double-Blind, Active-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Tegoprazan for the Prevention of Peptic Ulcer in Patients on Continuous Long-Term Treatment with Nonsteroidal Anti-Inflammatory DrugsSang Gyun Kim, Tae-Oh Kim, Sung Woo Jung, et al.
Pageof 17